Global Percutaneous Transluminal Coronary Angioplasty Balloon Catheter Market Outlook to 2031

company logo

Dublin, Oct. 14, 2022 (GLOBE NEWSWIRE) — The report “Percutaneous Transluminal Coronary Angioplasty Balloon Catheters Market by Product, By Delivery Platform, By Conformity, By Balloon Material: Global Opportunities Analysis and Forecast industry, 2021-2031” has been added to from ResearchAndMarkets.com offer.

Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market was estimated at USD 1,201.23 Million in 2021 and is projected to reach USD 1,848.76 Million by 2031 with a forecast CAGR of 4.4% by 2022 to 2031.

An PTCA balloon catheter is a device with a balloon at the tip that can be inflated or deflated when in place to open, widen, or close a pathway. These are used in surgical procedures, with the most common applications being coronary heart disease and stent placement. Rising occurrences of cardiac disorders, increasing geriatric population, attractive reimbursement policies, and technical improvements are all contributing to the expansion of the balloon catheter market.

The market for balloon catheters for PTCA is growing, driven by the increase in the prevalence of lifestyle-related diseases and the increase in the geriatric population. This expansion can be attributed to advances in technology and the increase in the number of angioplasty procedures performed, due to the minimally invasive nature of the surgery. Atherosclerosis can cause peripheral and coronary arterial disease, which can lead to stroke, myocardial infarction and/or cardiovascular mortality.

Furthermore, rapid adoption of sophisticated technologies in the angioplasty segment, including drug-eluting and cutting balloons, is expected to drive the market expansion throughout the forecast period, especially in the developed nations. Additionally, angioplasty balloons have a higher success rate than traditional angioplasty techniques, which is expected to drive the market growth.

On January 30, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. COVID-19 is expected to have a negative impact on market growth. The current COVID-19 situation has resulted in limited population movements in hospitals. People are keen to avoid any form of surgery or diagnostic operations, except for emergencies, to reduce the risk of contracting COVID-19.

Additionally, hospitals have moved workers from cardiac departments to other departments in need, such as emergency departments or intensive care units (ICUs). All of these variables are expected to impact the growth of the market. Nevertheless, this slowdown in growth is expected to be temporary and the market is expected to grow significantly in the future.

The global PTCA balloon catheter market is segmented on the basis of product, compliance, delivery platform, and balloon material. Based on the product, it is segmented into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter and scoring balloon catheter. According to the administration platform, it is divided into over-the-wire and rapid exchange/monorail balloon catheters.

According to compliance, the PTCA balloon catheter market is categorized into semi-compliant and non-compliant. Depending on the balloon material, it is fragmented into polyolefin copolymer (POC), polyethylene (PE) and polyethylene terephthalate (PET). Regionally, it is analyzed across North America, Europe, Asia-Pacific and LAMEA.

The list of key players profiled in this report includes Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CR Bard, Inc., Cardinal Health, Inc., Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation and THE SPECTRANETICS CORPORATION.

Key players in the value chain include Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences Pvt. Ltd., and COOK MEDICAL INC.

Main benefits for stakeholders

  • This report provides a quantitative analysis of market segments, current trends, estimates and dynamics of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market analysis from 2021 to 2031 to identify the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Prominent Opportunities. .

  • Market research is offered with information related to key drivers, restraints, and opportunities.

  • Porter’s Five Forces analysis highlights the ability of buyers and suppliers to enable stakeholders to make profit-driven business decisions and strengthen their supplier-buyer network.

  • An in-depth analysis of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market segmentation helps to determine the existing market opportunities.

  • Major countries in each region are mapped according to their revenue contribution in the global market.

  • The positioning of market players facilitates benchmarking and provides a clear understanding of the current position of market players.

  • The report includes analysis of regional and global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market trends, key players, market segments, application areas and opportunity growth strategies of the PTCA balloon catheter market.

Main topics covered:

CHAPTER 1 INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW
3.1. Definition and scope of the market
3.2. Main conclusions
3.2.1. The best investment pockets
3.3. Porter’s Five Forces Analysis
3.4. Positioning of the best player
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Constraints
3.5.3. Opportunities
3.6. COVID-19 Market Impact Analysis

CHAPTER 4: BALLOON CATHETERS FOR PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market Size and Forecast
4.2 Normal balloon catheter
4.2.1 Key Market Trends, Growth Drivers and Opportunities
4.2.2 Market Size and Forecast, by Region
4.2.3 Market Analysis by Countries
4.3 Drug-eluting balloon catheter
4.3.1 Key Market Trends, Growth Drivers and Opportunities
4.3.2 Market Size and Forecast, by Region
4.3.3 Market Analysis by Countries
4.4 Cut the balloon catheter
4.4.1 Key Market Trends, Growth Drivers and Opportunities
4.4.2 Market Size and Forecast, by Region
4.4.3 Market Analysis by Countries
4.5 Scoring balloon catheter
4.5.1 Key Market Trends, Growth Drivers and Opportunities
4.5.2 Market Size and Forecast, by Region
4.5.3 Market Analysis by Countries

CHAPTER 5: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM
5.1 Presentation
5.1.1 Market Size and Forecast
5.2 Rapid exchange (RX) / monorail balloon catheter
5.2.1 Key Market Trends, Growth Drivers and Opportunities
5.2.2 Market Size and Forecast, by Region
5.2.3 Market Analysis by Countries
5.3 Balloon Catheter Over the Wire (OTW)
5.3.1 Key Market Trends, Growth Drivers and Opportunities
5.3.2 Market Size and Forecast, by Region
5.3.3 Market Analysis by Countries

CHAPTER 6: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY COMPLIANCE
6.1 Overview
6.1.1 Market Size and Forecast
6.2 Semi-Compliant
6.2.1 Key Market Trends, Growth Drivers and Opportunities
6.2.2 Market Size and Forecast, by Region
6.2.3 Market Analysis by Countries
6.3 Non-compliant
6.3.1 Key Market Trends, Growth Drivers and Opportunities
6.3.2 Market Size and Forecast, by Region
6.3.3 Market Analysis by Countries

CHAPTER 7: PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS MARKET, BY BALLOON MATERIAL
7.1 Overview
7.1.1 Market Size and Forecast
7.2 Polyolefin copolymer (POC)
7.2.1 Key Market Trends, Growth Drivers and Opportunities
7.2.2 Market Size and Forecast, by Region
7.2.3 Market Analysis by Countries
7.3 Polyethylene (PE)
7.3.1 Key Market Trends, Growth Drivers and Opportunities
7.3.2 Market Size and Forecast, by Region
7.3.3 Market Analysis by Countries
7.4 Polyethylene terephthalate (PET)
7.4.1 Key Market Trends, Growth Drivers and Opportunities
7.4.2 Market Size and Forecast, by Region
7.4.3 Market Analysis by Countries

CHAPTER 8: BALLOON CATHETERS FOR PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) MARKET, BY REGION

CHAPTER 9: CORPORATE LANDSCAPE
9.1. Introduction
9.2. The best winning strategies
9.3. Top 10 Player Product Mapping
9.4. Competitive Dashboard
9.5. Competitive heat map
9.6. Main developments

CHAPTER 10: COMPANY PROFILES
10.1 ALVI MEDICA
10.1.1 Company Overview
10.1.2 Company Overview
10.1.3 Operating business segments
10.1.4 Product Portfolio
10.1.5 Commercial performance
10.1.6 Key Strategic Movements and Developments
10.2 ABOTT LABORATORIES
10.2.1 Company Overview
10.2.2 Company Overview
10.2.3 Operating business segments
10.2.4 Product Portfolio
10.2.5 Commercial performance
10.2.6 Key Strategic Movements and Developments
10.3 BOSTON SCIENTIFIC CORPORATION
10.3.1 Company Overview
10.3.2 Company Overview
10.3.3 Operating business segments
10.3.4 Product Portfolio
10.3.5 Commercial performance
10.3.6 Key Strategic Movements and Developments
10.4 BECTON, DICKINSON & COMPANY
10.4.1 Company Overview
10.4.2 Company Overview
10.4.3 Operating business segments
10.4.4 Product Portfolio
10.4.5 Commercial performance
10.4.6 Key Strategic Movements and Developments
10.5 IVASCULAR
10.5.1 Company Overview
10.5.2 Company Overview
10.5.3 Operating business segments
10.5.4 Product Portfolio
10.5.5 Commercial performance
10.5.6 Key Strategic Movements and Developments
10.6 RONSTIS
10.6.1 Company Overview
10.6.2 Company Overview
10.6.3 Operating business segments
10.6.4 Product Portfolio
10.6.5 Commercial performance
10.6.6 Key Strategic Movements and Developments
10.7 KONINKLIJKE PHILLIPS
10.7.1 Company Overview
10.7.2 Company Overview
10.7.3 Operating business segments
10.7.4 Product Portfolio
10.7.5 Commercial performance
10.7.6 Key Strategic Movements and Developments
10.8 MEDTRONIC controller
10.8.1 Company Overview
10.8.2 Company Overview
10.8.3 Operating business segments
10.8.4 Product Portfolio
10.8.5 Commercial performance
10.8.6 Key Strategic Movements and Developments
10.9 BALTON SP ZOO
10.9.1 Company Overview
10.9.2 Company Overview
10.9.3 Operating business segments
10.9.4 Product Portfolio
10.9.5 Commercial performance
10.9.6 Key Strategic Movements and Developments
10.10 B.BRAUN MELSUNGEN AG
10.10.1 Company Overview
10.10.2 Company Overview
10.10.3 Operating business segments
10.10.4 Product Portfolio
10.10.5 Commercial performance
10.10.6 Key Strategic Movements and Developments

For more information about this report visit https://www.researchandmarkets.com/r/xp4gr4

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900